BETA-PERIPAPILLARY ATROPHY AND GEOGRAPHIC ATROPHY IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS.

Kolomeyer, Anton M; Smith, Eli; Daniel, Ebenezer; Ying, Gui-Shuang; Pan, Wei; Pistilli, Max; Grunwald, Juan; Maguire, Maureen G; Kim, Benjamin J

Kolomeyer, Anton M; Smith, Eli; Daniel, Ebenezer; Ying, Gui-Shuang; Pan, Wei; Pistilli, Max; Grunwald, Juan; Maguire, Maureen G; Kim, Benjamin J.

Affiliation

Kolomeyer AM; Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Retina ; 41(1): 125-134, 2021 Jan 01.

Article in En | MEDLINE | ID: mdl-32383840

Subject(s)

Bevacizumab/administration & dosage; Clinical Trials as Topic/methods; Geographic Atrophy/drug therapy; Macular Degeneration/drug therapy; Ranibizumab/administration & dosage; Visual Acuity; Aged; Angiogenesis Inhibitors; Female; Fluorescein Angiography/methods; Follow-Up Studies; Geographic Atrophy/diagnosis; Humans; Intravitreal Injections; Macular Degeneration/diagnosis; Male; Retrospective Studies; Time Factors; Vascular Endothelial Growth Factor A/antagonists & inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Visual Acuity / Clinical Trials as Topic / Geographic Atrophy / Bevacizumab / Ranibizumab / Macular Degeneration Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google